n-methyl-3,4-methylenedioxyamphetamine has been researched along with 1,7-dimethylxanthine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carbó, ML; de la Torre, R; Farre, M; Langohr, K; Mathuna, BÓ; Mustata, C; Pardo, R; Perez-Mañá, C; Torrens, M; Yubero-Lahoz, S | 1 |
1 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and 1,7-dimethylxanthine
Article | Year |
---|---|
Changes in CYP1A2 activity in humans after 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) administration using caffeine as a probe drug.
Topics: Adult; Area Under Curve; Caffeine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Female; Half-Life; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Sex Factors; Theophylline | 2012 |